Cargando…
Faecalibacterium prausnitzii Ameliorates Colorectal Tumorigenesis and Suppresses Proliferation of HCT116 Colorectal Cancer Cells
Faecalibacterium prausnitzii is one of the most abundant commensals of gut microbiota that is not commonly administered as a probiotic supplement. Being one of the gut’s major butyrate-producing bacteria, its clinical significance and uses are on the rise and it has been shown to have anti-inflammat...
Autores principales: | Dikeocha, Ifeoma Julieth, Al-Kabsi, Abdelkodose Mohammed, Chiu, Hsien-Tai, Alshawsh, Mohammed Abdullah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138996/ https://www.ncbi.nlm.nih.gov/pubmed/35625865 http://dx.doi.org/10.3390/biomedicines10051128 |
Ejemplares similares
-
Role of probiotics in patients with colorectal cancer: a systematic review protocol of randomised controlled trial studies
por: Dikeocha, Ifeoma Julieth, et al.
Publicado: (2020) -
Investigation into the Potential Role of Propionibacterium freudenreichii in Prevention of Colorectal Cancer and Its Effects on the Diversity of Gut Microbiota in Rats
por: Dikeocha, Ifeoma Julieth, et al.
Publicado: (2023) -
Faecalibacterium prausnitzii Inhibits Interleukin-17 to Ameliorate Colorectal Colitis in Rats
por: Zhang, Mingming, et al.
Publicado: (2014) -
Investigation into the Molecular Mechanisms underlying the Anti-proliferative and Anti-tumorigenesis activities of Diosmetin against HCT-116 Human Colorectal Cancer
por: Koosha, Sanaz, et al.
Publicado: (2019) -
Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease?
por: Jia, Wenjing, et al.
Publicado: (2010)